Regulating Satiety Pathways: In the hypothalamus, GLP-1 RAs stimulate neurons that promote satiety (POMC/CART neurons) and inhibit neurons that drive hunger (NPY/AgRP neurons), reducing food intake and enhancing fullness (Zheng et al., 2024)
This effect is often the desired outcome for those taking this medication, yet additional considerations exist in practice and warrant clinical management
What happens if my weight starts creeping back up while on maintenance
Utilizamos o suplemento antes das sesses de corrida e musculao, onde pudemos observar melhorias no desempenho geral
The body may temporarily reduce non-essential energy expenditure, manifesting as fatigue, as it adapts to the new metabolic environment
86,87,88 Liraglutide was first approved by the FDA in 2010 under the brand name Victoza for the treatment of T2DM